Saint Louis University

Targeting the neuromuscular junction for treatment

Title:
Targeting the neuromuscular junction for treatment

Category:
Therapeutic

NCS:
Inventors:
Henry J. Kaminski, Linda L. Kusner, Namita Satiya

Summary:
The neuromuscular junction is the synapse or junction of the axon terminal of a neuron within a muscle fiber plasma membrane. Several diseases involve the neuromuscular junction as the primary site of injury. Examples include myasthenia gravis, Lambert-Eaton syndrome and Miller Fischer syndrome. This invention relates to compositions and methods useful for targeting therapeutic agents to the neuromuscular junction using neuromuscular junction targeting peptides.

Patent:
U.S. and foreign patents pending

Manager:
Stephanie Kimzey, MBA

 


© 1818 - 2015  SAINT LOUIS UNIVERSITY   |   Disclaimer   |  Mobile Site
St. Louis   |   Madrid